Revolutionising blood pressure monitoring is EU-based MedTech company Aktiia has developed an innovative cuffless monitor in the form of a wearable bracelet that tracks the wearer’s blood pressure 24/7 and records the data in the easily accessible Aktiia App.
The company has conducted extensive research over the last 18 years, comprised in part by its over 120 peer-reviewed publications, over 35 collective patents, and 5 clinical trials – and more – Aktiia is truly changing the way patients and physicians understand and control cardiovascular health.
Not only is the company well-backed by research, but it is also well-funded by some of the top investors in Europe and the US. The company is actively working on completing another funding round and launching its product in the US as it has set a goal to help 100M people control their blood pressure by 2032.
Freddie
Company Specialist at Welcome to the Jungle